Picture of IDEXX Laboratories logo

IDXX — IDEXX Laboratories News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareBalancedLarge CapHigh Flyer

Brief: IDEXX Q3 EPS USD 2.8 Vs. IBES Estimate USD 2.68

Oct 31 (Reuters) - IDEXX Q3 revenue USD 976 million vs. IBES estimate USD
979.2 million.
* Q3 gross margin 61.1%
* Q3 EBIT margin 31.2%
* outlook FY EPS USD 10.37-10.53
* outlook FY revenue growth 5.5-6.2%
* outlook FY revenue USD 3,865-3,890 million

Recent news on IDEXX Laboratories

See all news